Pull up the savings card and show the pharmacist along with your prescription
Ask your healthcare provider to write or e-prescribe Lamotrigine Starter Kit (Orange, Blue, and Green) DAW-1 on your prescription so you’ll receive the Lamotrigine Starter Kit at the pharmacy. You will pay as little as $5 if your insurance covers the Starter Kit. If you are cash paying or your commercial insurance plan does not cover the Lamotrigine Starter Kit, you will pay as little as $50 for any Starter Kit with the use of the Patient Savings Card.
Present this Savings Card (either printed OR on a mobile device) along with your prescription to the pharmacist and request the Lamotrigine Starter Kit.
When picking up your prescription, check the bag and the kit label to confirm that you received the Lamotrigine Starter Kit.
When calling please note the following NDC codes for each Starter Kit:
Orange Starter Kit
NDC 69102-137-10
Blue Starter Kit
NDC 69102-639-09
Green Starter Kit
NDC 69102-359-11
*Program Restrictions: Not eligible if prescriptions are paid by any state or federally funded programs, including, but not limited to Medicare, Medicaid, VA, DOD, Tricare or Medigap. Void where prohibited by law. Not valid for a Lamotrigine Starter Kit prescription reimbursed in full by any third-party payer. May not be combined with any other coupon, discount, savings card or other offer. May not be accepted at all pharmacies. Starter Kit: Limited to one prescription per person for any 35-day period. No substitutions permitted.
This offer may be terminated, rescinded, revoked or amended by OWP Pharmaceuticals, Inc. at any time, without notice.
For general questions or inquiries please contact us at: info@owppharma.com
For Lamotrigine Starter Kit questions please contact us at: medinfo@owppharma.com
To report safety-related concerns please contact us at: safety@owppharma.com
OWOS1084V5 3/24
© 2024 OWP Pharmaceuticals, Inc. All rights reserved. Naperville, IL 60563. Developed in USA.
WARNING: SERIOUS SKIN RASHES
Cases of life-threatening serious rashes, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and/or rash-related death have been caused by Lamotrigine. The rate of serious rash is greater in pediatric patients than in adults. Additional factors that may increase the risk of rash include:
Benign rashes are also caused by Lamotrigine; however, it is not possible to predict which rashes will prove to be serious or life threatening. Lamotrigine should be discontinued at the first sign of rash, unless the rash is clearly not drug related.
Please refer to the full Prescribing Information for Lamotrigine Tablets, including Medication Guide at www.lamotriginestarterkits.com.Lamotrigine tablets, USP are indicated for: Epilepsy—adjunctive therapy in patients aged 2 years and older::
Epilepsy—monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug.
Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy.
LIMITATIONS OF USE
Treatment of acute manic or mixed episodes is not recommended. Effectiveness of Lamotrigine in the acute treatment of mood episodes has not been established.
CONTRAINDICATIONS
Lamotrigine is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.
WARNINGS & PRECAUTIONS
DOSING GUIDELINES & CONSIDERATIONS
ADVERSE REACTIONS
Please refer to the full Prescribing Information for Lamotrigine Tablets, including Medication Guide at www.lamotriginestarterkits.com.
02/2023